Bone Marrow TransplantationTransplantation, HomologousBone MarrowHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation, AutologousGraft vs Host DiseaseSurvivorsStem CellsStem Cell TransplantationTransplantation ConditioningWhole-Body IrradiationTissue DonorsHematopoietic Stem CellsGraft SurvivalKidney TransplantationAnemia, AplasticLeukemiaBone and BonesHematologic NeoplasmsHistocompatibility TestingTransplantation ChimeraHistocompatibilityBusulfanImmunosuppressive AgentsTreatment OutcomeTransplantationGraft RejectionBone Marrow PurgingLiver TransplantationRecurrenceTime FactorsCytomegalovirus InfectionsCyclophosphamideRetrospective StudiesCombined Modality TherapyHeart TransplantationTransplantation, IsogeneicHematopoiesisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunocompromised HostHepatic Veno-Occlusive DiseasePeripheral Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteImmunosuppressionMice, Inbred C57BLPrecursor Cell Lymphoblastic Leukemia-LymphomaBone Marrow DiseasesLung TransplantationTransplantsOpportunistic InfectionsCell DifferentiationTransplantation ImmunologyRemission InductionSurvival AnalysisAcute DiseaseCyclosporineHematologic DiseasesRadiation ChimeraLymphocyte DepletionFollow-Up StudiesLeukocyte TransfusionLymphoma, Non-HodgkinSurvival RateHLA AntigensLeukemia, MyeloidEmbryonic Stem CellsBone Marrow ExaminationT-LymphocytesMultiple MyelomaHematopoietic Stem Cell MobilizationAdult Stem CellsMyelodysplastic SyndromesAntineoplastic Combined Chemotherapy ProtocolsFatal OutcomeMesenchymal Stem Cell TransplantationColony-Forming Units AssayBone RemodelingGraft vs Host ReactionCord Blood Stem Cell TransplantationAntigens, CD34AspergillosisBone Marrow NeoplasmsCells, CulturedMycosesFlow CytometryPostoperative ComplicationsChimeraGraft vs Leukemia EffectCytomegalovirusOrgan TransplantationMelphalanGranulocyte Colony-Stimulating FactorDisease-Free SurvivalPrognosisSevere Combined ImmunodeficiencyRisk FactorsProspective StudiesLymphocyte TransfusionLiving Donors